[$CHMA](Why this is a 4am play for me)

 

[Disclaimer]:  I am not a professional, I expect you to do your own research and due diligence on any investment or trade that you may perform.  None of the following is financial advice in any way shape or form.  Trade at your own risk.

 

Chiasma Inc is a biopharmaceutical company that focuses on improving the lives of patients who face challenges associated with existing treatments for their rare and debilitating diseases. Its product candidate includes octreotide capsule which has completed Phase III clinical trial and it is being developed for the potential treatment of acromegaly, a rare, debilitating disease. The company offers its products in the United States and the European Union.

 

+ Chiasma Announces FDA Approval of MYCAPSSA® (Octreotide) Capsules, the First and Only Oral Somatostatin Analog <June 26th>

"The current stock price going into this FDA news release was already overvalued and the stock quickly spiked initially and then cracked hard as those riding the uptrend sold off."

+ HC Wainwright & Co. Maintains Buy on Chiasma, Raises Price Target to $11 <June 29th>

+ Chiasma's Valuation Should Be Higher Than $5-6/Share Now That Mycapssa Is FDA Approved <June 30th>

"Very bullish sentiment shown towards Chiasma with a 100% upside"

+ Chiasma Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants <June 30th a/h>

"Price cracks hard on offering with no terms disclosed, I love these plays even when I'm not currently holding a long position.  Perfect average down spot for me, perfect low entry to swing long for anyone else"

+ Chiasma Inc granted patent for "Method of Treating Diseases" http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=10695397&OS=10695397&RS=10695397

 

"Just more fuel to the fire baby, to the moon!!!"